KMT2D and colorectal cancer: We further employed 15N-glutamine tracing in MLL4 WT (SW1417 and Caco2) and MLL4 truncation mutation (RKO and HCT116) colorectal cancer cells and demonstrated that mutant cells exhibited increased flux through de novo purine synthesis relative to their WT counterparts (Supplemental Figure 12, A and B).